House Passes Defense Bill Including Attack on Military Families’ Transgender Youth
WASHINGTON — The U.S. House of Representatives today passed a version of the National Defense Authorization Act that would ban coverage for gender-affirming care for transgender youth whose parents are active-duty military personnel. The American Civil Liberties Union is opposing final passage of the defense bill over the inclusion of this health care ban and scoring the vote.
Section 708 of the NDAA would prohibit insurance coverage for “medical interventions for the treatment of gender dysphoria” such as hormone therapy and puberty-suppressant medications, which Speaker Mike Johnson says would “permanently ban transgender medical treatment for minors.” The same treatments would be covered by TRICARE for any medical purpose other than treating gender dysphoria, the clinical diagnosis for the psychological distress experienced by transgender people related to their gender identity.
“It is shameful that a traditionally bipartisan, non-controversial bill would be turned into a targeted weapon against transgender youth and their parents in uniform,” said Mike Zamore, National Director of Policy & Government Affairs at the ACLU. “In the interests of scoring political points, this measure strips hundreds of young people of the health care they need, putting Members of Congress in between servicemembers, their children, and their doctors.. We strongly urge members of the Senate to pass a clean version of the NDAA and likewise urge President Biden to uphold his longstanding legacy of support for the LGBTQ community and the principle of keeping politics out of health care by vetoing it should it reach his desk.”
If passed by the Democratic-controlled Senate and signed into law by President Biden, this health care ban would be the first new anti-LGBTQ provision enacted by Congress since the passage of “Don’t Ask, Don’t Tell” and the so-called “Defense of Marriage Act” in the 1990s.
It is unknown how many transgender youth are currently enrolled in TRICARE or how many of those enrolled are currently receiving coverage for gender-affirming care. In one 2022 analysis, 2,500 minor patients sought care for gender dysphoria through TRICARE Prime insurance at military or civilian treatment facilities in 2017, and 900 received puberty-suppressants or gender-affirming hormones. That amounts to one tenth of one percent (or 0.1%) of the 918,000 youth aged 6 to 18 years who have at least one parent on active-duty or ready reserve military status. TRICARE has covered gender-affirming treatments for transgender youth since 2016.
Last week, the Supreme Court heard oral arguments in a landmark case brought by the ACLU, the ACLU of Tennessee, Lambda Legal, and Akin Gump on behalf of three families and a medical provider challenging a Tennessee ban on gender-affirming hormonal therapies for transgender youth on the grounds the ban violates the Equal Protection Clause of the U.S. Constitution.